These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14505891)

  • 1. A recA deletion mutant of Mycobacterium bovis BCG confers protection equivalent to that of wild-type BCG but shows increased genetic stability.
    Sander P; Böttger EC; Springer B; Steinmann B; Rezwan M; Stavropoulos E; Joseph Colston M
    Vaccine; 2003 Oct; 21(27-30):4124-7. PubMed ID: 14505891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant.
    Keller PM; Böttger EC; Sander P
    BMC Microbiol; 2008 Jul; 8():120. PubMed ID: 18637199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium bovis BCG recA deletion mutant shows increased susceptibility to DNA-damaging agents but wild-type survival in a mouse infection model.
    Sander P; Papavinasasundaram KG; Dick T; Stavropoulos E; Ellrott K; Springer B; Colston MJ; Böttger EC
    Infect Immun; 2001 Jun; 69(6):3562-8. PubMed ID: 11349014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium bovis BCG moreau is naturally deficient in homologous recombination.
    Schwarz MGA; Corrêa PR; Malaga W; Guilhot C; Mendonça-Lima L
    Tuberculosis (Edinb); 2020 Jul; 123():101956. PubMed ID: 32741533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of avirulent mutants of Mycobacterium bovis with vaccine properties by the use of illegitimate recombination and screening of stationary-phase cultures.
    Collins DM; Wilson T; Campbell S; Buddle BM; Wards BJ; Hotter G; de Lisle GW
    Microbiology (Reading); 2002 Oct; 148(Pt 10):3019-3027. PubMed ID: 12368435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis.
    Sander P; Clark S; Petrera A; Vilaplana C; Meuli M; Selchow P; Zelmer A; Mohanan D; Andreu N; Rayner E; Dal Molin M; Bancroft GJ; Johansen P; Cardona PJ; Williams A; Böttger EC
    Vaccine; 2015 Mar; 33(11):1353-9. PubMed ID: 25657094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
    Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ
    Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The genetic regulation of host response to inoculation with Mycobacterium bovis (BCG) and Mycobacterium tuberculosis H37RV].
    Nikonenko BV; Mezhlumova MB; Moroz AM
    Biull Eksp Biol Med; 1990 Nov; 110(11):526-8. PubMed ID: 2128037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene replacement by homologous recombination in Mycobacterium bovis BCG.
    Norman E; Dellagostin OA; McFadden J; Dale JW
    Mol Microbiol; 1995 May; 16(4):755-60. PubMed ID: 7476169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-exposure vaccination with the vaccine candidate Bacillus Calmette-Guérin ΔureC::hly induces superior protection in a mouse model of subclinical tuberculosis.
    Gengenbacher M; Kaiser P; Schuerer S; Lazar D; Kaufmann SH
    Microbes Infect; 2016 May; 18(5):364-8. PubMed ID: 26994939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.
    Liang J; Teng X; Yuan X; Zhang Y; Shi C; Yue T; Zhou L; Li J; Fan X
    Mol Immunol; 2015 Aug; 66(2):392-401. PubMed ID: 25974877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design of diagnostic and vaccination strategies for tuberculosis.
    Borsuk S; Seixas FK; Ramos DF; Mendum T; McFadden J; Dellagostin O
    Braz J Infect Dis; 2012; 16(1):68-73. PubMed ID: 22358359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis.
    Mahairas GG; Sabo PJ; Hickey MJ; Singh DC; Stover CK
    J Bacteriol; 1996 Mar; 178(5):1274-82. PubMed ID: 8631702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and complementation of a recA deletion mutant of Mycobacterium smegmatis reveals that the intein in Mycobacterium tuberculosis recA does not affect RecA function.
    Papavinasasundaram KG; Colston MJ; Davis EO
    Mol Microbiol; 1998 Nov; 30(3):525-34. PubMed ID: 9822818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis.
    Sambandamurthy VK; Derrick SC; Hsu T; Chen B; Larsen MH; Jalapathy KV; Chen M; Kim J; Porcelli SA; Chan J; Morris SL; Jacobs WR
    Vaccine; 2006 Sep; 24(37-39):6309-20. PubMed ID: 16860907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.